Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S. Lemoli RM, et al. Among authors: curti a. Haematologica. 1998 Jan;83(1):48-55. Haematologica. 1998. PMID: 9542323 Clinical Trial.
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purging.
Isidori A, Motta MR, Tani M, Terragna C, Zinzani P, Curti A, Rizzi S, Taioli S, Giudice V, D'Addio A, Gugliotta G, Conte R, Baccarani M, Lemoli RM. Isidori A, et al. Among authors: curti a. Biol Blood Marrow Transplant. 2007 Oct;13(10):1224-32. doi: 10.1016/j.bbmt.2007.07.004. Epub 2007 Aug 24. Biol Blood Marrow Transplant. 2007. PMID: 17889360 Free article. Clinical Trial.
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
Curti A, Tosi P, Comoli P, Terragna C, Ferri E, Cellini C, Massaia M, D'Addio A, Giudice V, Di Bello C, Cavo M, Conte R, Gugliotta G, Baccarani M, Lemoli RM. Curti A, et al. Br J Haematol. 2007 Nov;139(3):415-24. doi: 10.1111/j.1365-2141.2007.06832.x. Br J Haematol. 2007. PMID: 17910631 Free article. Clinical Trial.
More ADO about IDO: GVHD.
Curti A, Trabanelli S, Lemoli RM. Curti A, et al. Blood. 2008 Mar 15;111(6):2950. doi: 10.1182/blood-2008-01-131540. Blood. 2008. PMID: 18942199 Free article. No abstract available.
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A, Trabanelli S, Onofri C, Aluigi M, Salvestrini V, Ocadlikova D, Evangelisti C, Rutella S, De Cristofaro R, Ottaviani E, Baccarani M, Lemoli RM. Curti A, et al. Haematologica. 2010 Dec;95(12):2022-30. doi: 10.3324/haematol.2010.025924. Epub 2010 Aug 26. Haematologica. 2010. PMID: 20801903 Free PMC article.
217 results